Phase 1 trial initiated to assess safety/tolerability and absolute bioavailability of TH104 with topline data expected in 2Q24Planning well underway for Phase 2 of TH104 in primary biliary cholangitis (PBC) patients suffering from moderate-to-severe ch…
KFSH&RC-Madinah Receives Prestigious 2023 Press Ganey Human Experience Guardian of Excellence Award which is a prestigious award that highlights exceptional performance in outpatient services throughout one year. This prestigious recognition honored KFSH&RC-Madinah Receives Prestigious 2023 Press Ganey Human Experience Guardian of Excellence Award which is a prestigious award that highlights
KFSH&RC-Madinah Receives Prestigious 2023 Press Ganey Human Experience Guardian of Excellence Award which is a prestigious award that highlights exceptional performance in outpatient services throughout one year. This prestigious recognition honored KFSH&RC-Madinah Receives Prestigious 2023 Press Ganey Human Experience Guardian of Excellence Award which is a prestigious award that highlights
SHELTON, CT / ACCESSWIRE / January 29, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today that the hea…
STOCKHOLM, SWEDEN / ACCESSWIRE / January 29, 2024 / PMD Device Solutions (STO:PROMO)(FRA:8T0) In connection with the reverse share split, whereby 128 shares are combined into one (1) new share, PMDS will receive a new ISIN code.The last day of trading …
Benevity platform saw 38% year-over-year growth in grants processedCALGARY, AB / ACCESSWIRE / January 29, 2024 / Benevity Inc., the leading provider of global corporate purpose software, today announced a surge in corporate granting, with 38% year-over…